Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
9,953 total articles
Acadia Pharmaceuticals’ Principal Accounting Officer, James Kihara, conducted a recent sale of company stock. This activity occurs against the backdrop of the firm's first quarter 2026 financial results, which missed analyst expectations on both earnings per share and revenue. Despite these headwinds, key financial metrics suggest certain areas of …
Bryan M Corsini, Chief Credit Officer at Banc of California (NASDAQ:BANC), sold a total of $285,731 worth of common stock shares on May 26, 2026. This transaction occurs against a backdrop of strong performance for the bank's stock, which has risen 39% over the past year. Furthermore, Banc of California recently reported financial results that surp…
Serge Saxonov, Chief Executive Officer of 10x Genomics, Inc. (NASDAQ:TXG), executed two separate sales last week, disposing of a total of 28,893 shares of Class A Common Stock valued at approximately $709,057. These transactions occurred while the stock trades near its annual high and following various analyst assessments.
Benjamin Hindson, President and Chief Scientific Officer of 10x Genomics, Inc., recently sold shares of the company's Class A Common Stock. This transaction occurred while the stock was trading near its yearly high, amidst broader positive developments including an 'Outperform' rating from William Blair and a price target increase from Stifel. Howe…
The recent activity of 10x Genomics, Inc. (NASDAQ:TXG), including a reported stock sale by its CFO and significant corporate partnerships, paints a complex picture for investors. While William Blair upgraded the rating to Outperform and Stifel raised price targets citing product adoption, concerns persist regarding institutional shifts and potentia…
Vice President, Corporate Controller, and Chief Accounting Officer at Itron, Inc. (NASDAQ:ITRI), David Marshall Wright, recently sold a block of company stock. This transaction occurred while the company reported robust first-quarter financial results, though some analyst sentiment remains cautious following an adjusted price target reduction.
A director of American Integrity Insurance Group, Inc. (NASDAQ:AII) executed a significant purchase of the company's common stock. This transaction occurs while the stock is trading close to its 52-week low. The buying activity takes place against a backdrop of recent mixed investor sentiment following the release of first-quarter 2026 earnings.
The market observed a transaction involving an executive at Itron, Inc. (NASDAQ:ITRI), specifically the sale of company stock by Senior Vice President Christopher E. Ware. This activity occurred alongside recent corporate financial disclosures, including Q1 2026 earnings results that exceeded expectations for both earnings per share and revenue. Ho…
The Chief Operating Officer of Kymera Therapeutics, Jeremy G. Chadwick, executed multiple stock sales in late May 2026, disposing of a total value of approximately $1.37 million. These insider transactions occurred while the company reported robust first-quarter financial results and presented positive data from its ongoing clinical and preclinical…
Senior Vice President Donald L. Reeves III sold company shares, a transaction occurring as Itron stock faces mixed signals from both financial performance reports and external analyst downgrades. While the company reported strong first-quarter earnings and revenue figures, investor sentiment was tempered by concerns over near-term growth trajectori…
Itron, Inc. (NASDAQ:ITRI) saw a recent transaction involving the sale of company common stock by its Senior Vice President of Human Resources. This activity occurred against a backdrop of mixed market signals for Itron. While the company reported better-than-expected financial results for the first quarter of 2026, including earnings and revenue th…
Insider activity at ITRON, INC. (NASDAQ:ITRI) was noted on May 26, 2026, when Senior Vice President Patrick Justin K sold company stock. This transaction involved the disposal of 216 shares, valued at $18,223, which were automatically sold to cover tax withholding related to a restricted stock unit award. Despite this insider action, the company re…
Director Andrew C. Richardson recently sold 2,000 shares of Alpine Income Property Trust's common stock over two separate transactions totaling $38,513. This sale occurred against a backdrop of positive sector developments for the trust, including an upgrade to 'Strong Buy' from Raymond James and increased price targets following revised financial …
Wayne-Kent A. Bradshaw, a director at Broadway Financial Corp (NASDAQ:BYFC), recently executed a series of stock sales totaling $81,048. These transactions were reported via SEC filings on May 26, 2026. The sale involved disposing of 8,600 shares of the company's common stock across multiple price points, ranging from $9.36 to $9.68 per share.The t…
The article details a recent insider transaction by an Itron executive, John F. Marcolini, alongside the company's strong first-quarter financial results for 2026. While Itron surpassed expectations in revenue and EPS, the stock faced pre-market concerns, and analysts also adjusted their price targets.
Andrew J. Briggs, a director at Farmers & Merchants Bancorp Inc., recently completed the sale of 6,000 shares of company common stock over two days. This transaction occurred against a backdrop of positive corporate developments for the bank, including an announced increase in its quarterly cash dividend and several internal leadership promotions.
Joan S. Hooper, Senior Vice President and Chief Financial Officer of Itron, Inc., completed a common stock sale valued at $37,290 on May 26, 2026. This transaction involved the disposal of 442 shares priced at $84.3667 per share, with the proceeds automatically covering tax withholding obligations related to the vesting of a restricted stock unit a…
A director at Broadway Financial Corp (NASDAQ:BYFC) executed a sale of company stock in May 2026. The transaction involved selling 1,400 shares for approximately $13,403. While the stock is currently trading near its 52-week high and showing strong recent performance, Mr. Bradshaw's reported holdings reflect adjustments from past corporate actions.
The Chief Executive Officer of Itron, Inc., Deitrich Thomas, recently sold a block of company shares. This transaction occurred alongside mixed market signals regarding the stock's valuation, noting both underperformance over the past year and strong first-quarter financial results. Despite positive earnings, analysts have adjusted price targets do…
The Chief Financial Officer of IBEX Ltd, Taylor C. Greenwald, recently executed stock trades involving both disposals and acquisitions on May 22, 2026. These transactions occurred against a backdrop of positive company performance, including exceeding revenue forecasts and the announcement of a significant share repurchase program.
John M. Markovich, Chief Financial Officer of D-Wave Quantum Inc., recently sold a substantial amount of company stock totaling $9.1 million following the exercise of options. This activity occurred against a backdrop of significant stock performance for D-Wave, which also announced key operational and financial updates, including an earnings beat …
Analysis of recent SEC filings reveals transactions by former Allstate officer Mark Q. Prindiville, including the sale of stock. This activity occurs against a backdrop of strong first-quarter financial results for Allstate Corporation. The company reported earnings per share and revenue significantly surpassing analyst expectations, while an exter…
Recent filings indicate that a senior executive at Vicor Corp sold a significant amount of company stock. This activity occurs against a backdrop of robust financial performance for the first quarter of 2026. The company reported strong earnings per share and significantly raised its second-quarter revenue guidance, leading an analyst firm to raise…
Kyle Pilkington, the Chief Legal Officer of SES AI Corp, executed a sale of company shares totaling $30,007. This transaction was conducted through a pre-arranged Rule 10b5-1 trading plan. Separately, the company reported its first quarter 2026 earnings, which presented a mixed picture: while meeting EPS expectations, revenue fell below anticipated…
SLB Chief Executive Officer Olivier Le Peuch recently executed a stock sale totaling $1.42 million, involving 25,000 shares of the company's common stock. This transaction occurred while SLB was trading near its annual high and amidst multiple positive analyst reports that have raised price targets and highlighted the company's strong operational p…
